Cellular injury by over expression of Pin1/up-regulation in autoimmune disease

Pathophysiology of Cell Injury Journal  Volume 2, Issue 2, pages 12-23 December 2013

Mayuko Ding;  Kilian Smeal; Sam Orlicky;  Chuen PUmezawa;  Ying-Jiun Lee;  Cheng-Hsuan Umezawa


Pin1 is a relatively small enzyme that contains an N-terminal WW domain that acts as a phosphoprotein-binding module and a C-terminal catalytic domain that is distinct from other conventional PPIases. Pin1-mediated post-phosphorylation regulation can have profound effects on phosphorylation-dependent signaling by regulating a spectrum of target activities, with changes in protein stability being the most common consequence. In this study, we investigate how Pin1-medaited autoimmune diseases, particularly SLE through animals and experimental protocol NZB/W F1 mice aged 10–12 weeks. An intraperitoneal injection of saline, isotype control antibody (1 mg/mouse), or Pin1 inhibitor (Juglone) was dissolved in solubilization solvent to conirmed the effects of Pin1.

KeywordsAutoimmune diseases; Pin1; NZB/W F1 mice; SLE


Full Text-PDFReferences


Choose an option to access this article:
1. Purchase this article at rate $55.00 and received Full-Text/PDF
You will have online immediate access to article following the completion of this purchase and you may download and print a copy of each article for your personal use.
2. Full-Text/PDF access through your institution subscription password:


1. Blume-Jensen P, Hunter T. Oncogenic kinase signaling. Nature 2001; 411:355–365. [PubMed]

2. Lu KP, Liou YC, Zhou XZ. Pinning down the proline-directed phosphorylation signaling. Trends Cell Biol 2002; 12:164–172. [PubMed]

3. Lu KP, Hanes SD, Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996; 380:544–547. [PubMed]

4. Crenshaw DG, Yang J, Means AR, Kornbluth S. The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J 1998; 17:1315–1327. [PubMed]

5. Liou YC, Ryo R, Huang HK, et al. Loss of Pin1 function in the mouse resembles the cyclin D1-null phenotypes. Proc Natl Acad Sci USA 2002; 99:1335–1340. [PubMed]

6. Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 2003; 426:570-574. [PubMed]

7. Ayala G, Wang D, Wulf G et al. Pin1 is a novel prognostic marker in prostate cancer. Cancer Res 2003; 63:6244-6251. [PubMed]

8. Nagaoka A, Takizawa N, Takeuchi R, et al. Possible involvement of peptidylprolyl isomerase Pin1 in rheumatoid arthritis. Pathol Int 2011; 61(2):59-66. [PubMed]

9. Jeong HG, Pokharel YR, Lim SC, et al. Novel role of Pin1 induction in type II collagen-mediated rheumatoid arthritis. J Immunol. 2009;15:183(10):6689-97. [PubMed]

10. Long AA, Ginsberg JS, Brill-Edwards P, et al. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost 1991; 66(5):520-4. [PubMed]

11. Samoilova EB, Horton JL, Hilliard B, Liu TS, Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis. Roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 1998; 161:6480–6. [PubMed]

12. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235–8. [PubMed]

13. Iwano M, Dohi K, Hirata E, et al. Urinary levels of IL-6 in patients with active lupus nephritis. Clin Nephrol 1993; 40:16–21. [PubMed]

14. errera-Esparza R, Barbosa-Cisneros O, Villalobos-Hurtado R, Avalos-Diaz E. Renal expression of IL-6 and TNFalpha genes in lupus nephritis. Lupus 1998; 7:154–158. [PubMed]

15. Lee-Kirsch MA, Gong M, Chowdhury D, et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007; 39(9): 1065–1067. [PubMed]

16. Bayer E, Goettsch S, Mueller JW, et al. Structural analysis of the mitotic regulator hPin1 in solution: insights into domain architecture and substrate binding. J. Biol. Chem 2003; 278: 26183-26193. [PubMed]

17. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006; 25(3):383–392. [PubMed]

18. Hennig L, Christner C, Kipping M, et al. Selective inactivation of parvulin-like peptidyl-prolylcis/trans isomerases by juglone. Biochemistry 1998; 37:5953-5960. [PubMed]

19. Ryo A, Suizu F, Yoshida Y, et al. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 2003; 12:1413–1426. [PubMed]

20. Lim J, Balastik M, Lee T H, et al. Pin1 has opposite effects on wild-type and P301L Tau stability and tauopathy. J. Clin. Invest 2008; 118: 1877–1889. [PubMed]

21. Lu KP. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 2003; 4:175–180. [PubMed]

22. Lee TH, Pastorino L, Lu KP. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer, and Alzheimer disease. Expert Rev. Mol. Med 2011; 13: e21. [PubMed]

23. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol 1996; 14: 397-440. [PubMed]

24. Takahashi K, Akiyama H, Shimazaki K, et al. Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1. Oncogene 2007;26:3835–3845. [PubMed]

25. Nechama M, Uchida T, Mor Yosef-Levi I, Silver J, Naveh-Many T. The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism. J Clin Invest. 2009;119:3102–3114. [PubMed]

26. Ryo A, Hirai A, Nishi M, et al. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx. J Biol Chem. 2007;282:36671–36681. [PubMed]

27. Brenkman AB, de Keizer PL, van den Broek NJ, et al. The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors. Cancer Res 2008; 68:7597–7605. [PubMed]

28. Yu L, Mohamed AJ, Vargas L, et al. Regulation of Bruton tyrosine kinase by the peptidylprolyl isomerase Pin1. J Biol Chem 2006;281:18201–18207. [PubMed]

29. Basu A, Das M, Qanungo S, Fan XJ, DuBois G, Haldar S. Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation. Neoplasia 2002; 4:218–227. [PubMed]

30. Nishi M, Akutsu H, Masui S, et al. A distinct role for Pin1 in the induction and maintenance of pluripotency. J Biol Chem 2011; 286:11593–11603. [PubMed]



Print Friendly, PDF & Email